AU2003260723A1 - Use of vinca alkaloyds, taxane, cryptophycine, ephitoline or eleutherobine for treating alzheimer - Google Patents
Use of vinca alkaloyds, taxane, cryptophycine, ephitoline or eleutherobine for treating alzheimerInfo
- Publication number
- AU2003260723A1 AU2003260723A1 AU2003260723A AU2003260723A AU2003260723A1 AU 2003260723 A1 AU2003260723 A1 AU 2003260723A1 AU 2003260723 A AU2003260723 A AU 2003260723A AU 2003260723 A AU2003260723 A AU 2003260723A AU 2003260723 A1 AU2003260723 A1 AU 2003260723A1
- Authority
- AU
- Australia
- Prior art keywords
- ephitoline
- alkaloyds
- eleutherobine
- cryptophycine
- taxane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/475—Quinolines; Isoquinolines having an indole ring, e.g. yohimbine, reserpine, strychnine, vinblastine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB0219241A GB0219241D0 (en) | 2002-08-17 | 2002-08-17 | Medicaments |
GBGB0219241.7 | 2002-08-17 | ||
GBGB0225206.2 | 2002-10-30 | ||
GBGB0225206.2A GB0225206D0 (en) | 2002-10-30 | 2002-10-30 | Medicaments |
PCT/GB2003/003601 WO2004016269A1 (en) | 2002-08-17 | 2003-08-18 | Use of vinca alkaloyds, taxane, cryptophycine, ephitoline or eleutherobine for treating alzheimer |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2003260723A1 true AU2003260723A1 (en) | 2004-03-03 |
Family
ID=31889682
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2003260723A Abandoned AU2003260723A1 (en) | 2002-08-17 | 2003-08-18 | Use of vinca alkaloyds, taxane, cryptophycine, ephitoline or eleutherobine for treating alzheimer |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003260723A1 (en) |
WO (1) | WO2004016269A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA05002113A (en) | 2002-08-23 | 2005-06-03 | Sloan Kettering Inst Cancer | Synthesis of epothilones, intermediates thereto, analogues and uses thereof. |
US7649006B2 (en) | 2002-08-23 | 2010-01-19 | Sloan-Kettering Institute For Cancer Research | Synthesis of epothilones, intermediates thereto and analogues thereof |
PL2276485T3 (en) | 2008-04-24 | 2014-12-31 | Bristol Myers Squibb Co | Use of epothilone d in treating tau-associated diseases including alzheimer's disease |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0870510A3 (en) * | 1997-04-11 | 1999-09-15 | Eli Lilly And Company | Synergistic combination comprising cryptophycin derivatives and microtubule synergizing agents |
-
2003
- 2003-08-18 WO PCT/GB2003/003601 patent/WO2004016269A1/en not_active Application Discontinuation
- 2003-08-18 AU AU2003260723A patent/AU2003260723A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2004016269A1 (en) | 2004-02-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2006003525A0 (en) | Ä1,8ÜNapthyridin-2-ones and related compounds for the treatment of schizophrenia. | |
EP1535971A4 (en) | Treated pigment, use thereof, and compound for pigment treatment | |
AU2002319538A1 (en) | Organic slurry treatment process | |
AU2003249244A1 (en) | Methods for the treatment of neoplasms | |
PL375532A1 (en) | Benzimidazol-1-yl-thiophene compounds for the treatment of cancer | |
WO2003073999A3 (en) | Pini-modulating compounds and methods of use thereof | |
AU2003237159A1 (en) | Treatment for phenylketonuria | |
WO2003074550A3 (en) | Pin1-modulating compounds and methods of use thereof | |
AU2003247624A1 (en) | Method of treating the syndrome of lipodystrophy | |
AU2003280298A1 (en) | Methods for the biological treatment of gas | |
AU2003212634A1 (en) | Compounds useful in the treatment of cancer | |
AU2003258145A1 (en) | Substituted phenylindoles for the treatment of hiv | |
AU2003290059A1 (en) | Use of cd137 antagonists for the treatment of tumors | |
EP1551388A4 (en) | Compounds useful for the treatment of cancer, compositions thereof and methods therewith | |
AU2003903242A0 (en) | Process for the treatment of wood | |
AU2003233820A1 (en) | Method for the treatment of starch | |
AU2003223538A1 (en) | Methods for the treatment of cancer | |
AU2003291886A1 (en) | Thiophenederivatives for the treatment of flavivirus infections | |
AU2003219160A1 (en) | Methods and compositions for the treatment of cancer | |
EP1575497A4 (en) | Novel composition and methods for the treatment of psoriasis | |
AU2003260723A1 (en) | Use of vinca alkaloyds, taxane, cryptophycine, ephitoline or eleutherobine for treating alzheimer | |
AU2003220026A1 (en) | Methods and compositions for the treatment of ischemia | |
AU2003258983A1 (en) | Combinations for the treatment of fungal infections | |
AU2003224486A1 (en) | Composition for treating cancer containing n,n-dimethylphytosphingosine | |
AU2003205452A1 (en) | Bmp inhibitors for the treatment of spondyloarthropathies |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |